Greenhy2 Limited Overview
H2G Limited is a Sydney-based, ASX-listed nano-cap that has undergone two complete business-model transformations in six years. Until 2022 it was Tempo Australia, an electrical, structural-mechanical-piping and asset-maintenance contractor serving mining, oil and gas, telecommunications and commercial clients, generating tens of millions of dollars of revenue. From 2021–2022 it divested that business and re-emerged as GreenHy2, an integrator of solid-state (metal hydride) hydrogen storage for diesel-replacement stand-alone power systems, anchored by a GKN Hydrogen distribution agreement and a federally grant-funded Telstra demonstration project. In 2025, citing a market-sentiment shift away from hydrogen, it pivoted again, making PowerSafe sodium-ion batteries, CEC-approved inverters, LFP batteries and Skeleton Technologies supercapacitors its primary offerings. It is pre-commercial in product terms, funded by small equity placements, R&D tax incentives and government grants, and its investment case rests on converting a disclosed A$4.5 million sodium-ion pipeline into sales.
Company's own description
In its latest periodic filings the company describes itself as one of Australia's leading innovators in engineering solutions for renewable energy, established in 2011, with expertise in renewable energy storage spanning low-pressure and solid-state hydrogen storage, supercapacitor batteries, electrolysers, fuel cells, associated equipment, digital interfaces and operation and maintenance support (HY2025 Appendix 4D cover announcement, 27 Aug 2025). The FY2025 Appendix 4E states that during FY2025 the company completed a major technology expansion beyond its original hydrogen products to include PowerSafe sodium-ion batteries, high-tech supercapacitors and PowerSafe LFP batteries, and that hydrogen became a secondary product because sentiment had moved away from hydrogen as a strong future contributor to the energy transition (FY2025 4E, p.1).
Notably, the formal "Principal Activities" paragraph in the HY2026 Directors' Report still reads as a legacy statement, describing the focus as renewable energy study, asset management, maintenance and construction across telecommunications, infrastructure, resources, power, industrial and commercial sectors (HY2026 report, p.6). This boilerplate lags the operational narrative and is itself a governance/disclosure-quality observation.
Independent characterisation
H2G is best characterised as an early-stage energy-storage product distributor and systems integrator rather than a manufacturer or technology developer. Its value-chain position is mid-stream: it sources cells, batteries, inverters, supercapacitors and hydrogen storage hardware from third-party OEMs (GKN Hydrogen historically; H2Core Systems for low-pressure hydrogen and supercapacitors; Skeleton Technologies for curved-graphene supercapacitors and SuperBattery; unnamed sodium-ion cell and inverter suppliers), brands and certifies them for Australian conditions under the PowerSafe name, and sells through a nascent network of installers and distributors. Its in-house intellectual property consists principally of capitalised development costs (A$2.23 million net carrying value at 30 June 2026) relating to system integration, sizing/modelling software developed under the Telstra project, and product adaptation.
Business model and revenue model
| Revenue stream | Model | Status (latest disclosure) |
|---|---|---|
| Government grant-funded project delivery (Telstra TDRIP Hy2MEDI) | Milestone-based project revenue recognised over time | Primary FY2025 revenue driver; project in performance evaluation phase (HY2026) |
| R&D tax incentive | Classified by the company within "revenue and other income" (A$557,097 in H1 2026) | Recurring annual refund (A$774,632.77 received 13 Jul 2026) |
| Product sales (sodium-ion, LFP batteries, inverters) | One-off product sale, revenue at point in time | First revenue Q4 FY2025; A$12,507 recognised in H1 2026; first Model S shipments in transit (HY2026) |
| Supercapacitor / SuperBattery solutions (Skeleton) | Project/product sale to data centres and critical infrastructure | Over A$10 million quoted; no orders disclosed (HY2026) |
| Hydrogen storage systems (Hy2 range) | Project/system sale | Secondary product; no commercial sales disclosed beyond grant-funded Telstra project |
| Turnkey solar + battery with finance options | Bundled product + installation (via installer partners) | Launched October 2025 (ASX Market Update 24 Oct 2025, per TipRanks) |
Product vs. service vs. subscription vs. licensing mix: in H1 2026, A$579,590 (97.9% of revenue) was classified as "services rendered over time" to government counterparties (including the R&D incentive and grant income), and A$12,507 (2.1%) as goods transferred at a point in time to commercial customers (HY2026 note 3). There is no subscription or licensing revenue disclosed. The HY2 Connect digital platform was marketed in the hydrogen era but has no disclosed revenue.
Customer types and end-markets
| Customer type | Examples / targets named by the company | Evidence of revenue |
|---|---|---|
| Federal government (grant funder) | Department of Infrastructure, Transport, Regional Development, Communications and the Arts (TDRI Program, Power Resilience Round) | Yes, dominant |
| Telecommunications | Telstra / Telstra InfraCo | Project partner (Telstra committed A$1.5 million to the project) |
| Utilities | Essential Energy (SAPS trial; multi-unit project subject to ARENA grant) | Trial only |
| Residential | Homeowners via installer network; turnkey solar/battery | First sodium-ion sales from Q4 FY2025 |
| Commercial & industrial (safety-critical) | Petrol stations, bushfire-prone properties, eco-resorts, real estate developers, utilities | Pipeline only |
| Data centres and critical infrastructure | Skeleton supercapacitor/SuperBattery offering | Quotations over A$10 million; no orders |
| Defence and transport | Named as addressable for Skeleton technologies | No disclosed activity |
Strategy
Stated strategy themes (latest filings, paraphrased)
The FY2025 4E and HY2026 Directors' Report articulate four strategic pillars: (1) continued launch of the PowerSafe sodium-ion battery and compatible inverter range engineered for Australian conditions, positioned on safety, affordability, longevity and recyclability; (2) building distribution and installation capability, including a national installation network and wholesale distribution agreements for residential and C&I customers; (3) commercialising the Skeleton Technologies MOU by moving data centres and critical infrastructure from lithium-ion to graphene supercapacitors and SuperBattery systems; (4) complementing sodium-ion with a CEC-registered PowerSafe LFP product eligible for rebates. Management frames the overall ambition as leadership in Australia's transition to safer, more sustainable and cost-effective storage. Hydrogen is explicitly downgraded to a secondary product (FY2025 4E).
Strategic initiative register (last 24 months)
| Date | Initiative | Type | Target / status |
|---|---|---|---|
| Oct 2024 | Telstra TDRIP Hy2MEDI project (A$1.5 million grant plus A$1.5 million Telstra) | Grant-funded demonstration | In performance evaluation (HY2026) |
| FY2024 | Hydrogen cost-out programme | Cost/supply chain | 30–50% cost saving; up to 65% shorter lead times (FY2024 4E) |
| Mar 2025 | H2Core technology contract | Supply partnership | Supercapacitors and LPH; approximately EUR 350,000 Telstra subcontract |
| Oct 2025 | PowerSafe sodium-ion launch; turnkey solar/battery with finance; Skeleton MOU; H2G rebrand | Product/brand pivot | Launched |
| Q4 2025 | Three product websites | Go-to-market | Live |
| 2025–2026 | Engagement with government and CEC for sodium-ion certification and rebate eligibility | Regulatory | Testing to SA TS 5398:2025; standard not yet expanded |
| Apr 2026 | Gen 2 battery and inverter completed; 50–500 kWh large-format product finalised | Product development | Completed (AGM 2026) |
| c. Apr 2026 | Corporate name change to H2G Limited | Branding | Completed |
| Q2 2026 | Model S stackable battery; three CEC-approved inverters; installers in four states | Product + channel | First shipments in transit |
| 2,026 | Data centre supercapacitor tendering | Business development | Over A$10 million quoted; slow conversion |
| 2026 AGM goals | Supply first supercapacitor batteries for data centres and critical infrastructure; actively promote Gen 2 sodium-ion into existing channels | Commercial targets | Pending |
Sustainability/ESG commitments
No formal emissions targets, sustainability report or climate-related financial disclosure are publicly disclosed. The company's product proposition (diesel replacement, non-flammable storage, recyclable cells) is its de facto ESG narrative.
Medium-term financial targets / guidance
None. The company explicitly defers revenue projections, stating they will be updated in future reports (FY2025 4E; HY2026). The only quantified forward indicators are pipeline figures: sodium-ion over A$4.5 million and supercapacitor quotations over A$10 million (HY2026; June 2026 quarterly). Pipeline is not backlog and carries no contractual commitment.
Products & Services
All products sit within the single renewable energy storage segment. Pricing is not publicly disclosed for any product.
PowerSafe Sodium-Ion Batteries (primary product line)
| Attribute | Detail |
|---|---|
| Description | Residential, commercial, industrial and utility sodium-ion battery range engineered for Australian conditions |
| Flagship | Model S (Stackable), formerly "Gen 2", completed Q2 FY2026; first shipments in transit at 19 Aug 2026 |
| Key claims (company) | No thermal runaway or fire risk; approximately 20-year life with 15-year warranty; operating range -30°C to +60°C; 100% recyclable; cell in Model S tested to UL9540A and claimed to be the first cell globally to pass nail penetration, overcharge and thermal runaway tests without fire or explosion (HY2026 Directors' Report). |
| Cost positioning | Company cites CATL forecasts of sodium-ion cell costs falling to around US$10/kWh, under one-third of lithium-ion (HY2026) |
| Certification status | Not yet on Clean Energy Council (CEC) approved battery list because the Australian Standard has not yet been expanded to sodium-ion; testing to SA TS 5398:2025 to enable quick registration; therefore not currently eligible for the federal battery rebate (HY2026) |
| Target customers | Residential; safety-critical C&I (petrol stations, bushfire-prone areas, unoccupied holiday homes, eco-resorts, developers) |
| Launch | Range launched October 2025 (ASX Market Update 24 Oct 2025); first sales Q4 FY2025; Model S Q2 FY2026 |
| Pipeline | About A$2 million (Feb 2026), over A$3 million (Apr 2026), over A$4.5 million (Jul–Aug 2026) |
| Cell supplier | — |
Large-format Sodium-Ion C&I / Utility product
| Attribute | Detail |
|---|---|
| Description | Large-format sodium-ion system in a 50 kWh to 500 kWh range |
| Status | Finalised per 2026 AGM presentation (30 Apr 2026); no sales disclosed |
| Target | Utilities, defence, data centres, community batteries, industrial users |
PowerSafe Hybrid Inverters
| Attribute | Detail |
|---|---|
| Description | Inverters designed to optimise sodium-ion chemistry; three new CEC-approved models introduced alongside Model S |
| Status | CEC approved, allowing installation on all Australian networks (HY2026) |
| Role | Removes grid-connection barrier even while the battery itself awaits CEC listing |
PowerSafe LFP (Lithium Iron Phosphate) Battery
| Attribute | Detail |
|---|---|
| Description | Lithium iron phosphate battery using A-grade long-life cells, positioned as a complement to sodium-ion |
| Certification | CEC-registered and eligible for full consumer rebates (FY2025 4E) |
| Channel | Turnkey solar/battery packages or standalone; www.residentialbatteries.com.au |
| Supplier | — |
Skeleton Technologies Supercapacitors and SuperBattery (distributed under MOU)
| Attribute | Detail |
|---|---|
| Description | Curved graphene-based supercapacitors and SuperBattery (hybrid supercapacitor) systems from Skeleton Technologies (Estonia/Germany) |
| Company-cited capabilities | High power density, ultra-fast charging, lifespans over 1 million cycles, 10 µs dynamic response, fire-safe, operation up to 50–60°C, up to 45% energy-efficiency improvement; peak-load shaving enabling up to 40% more FLOPS in data centres (FY2025 4E; HY2026) |
| Target | Data centres, critical infrastructure, high-security installations, transport, defence |
| Commercial status | More than A$10 million of quotations; conversion slow due to technical uncertainty among data centre operators about grid support and critical power (HY2026). No orders disclosed. |
| Contract form | Strategic MOU (non-binding character implied; terms not disclosed) |
H2Core supercapacitor batteries and low-pressure hydrogen (LPH)
| Attribute | Detail |
|---|---|
| Description | Graphene supercapacitor batteries and low-pressure hydrogen storage technologies from European supplier H2Core Systems |
| Contract | Signed March 2025; subcontract for Telstra microgrid technology supply about EUR 350,000, delivered progressively over six months; H2G not obliged to use H2Core products (MT Newswires, 24 Mar 2025) |
| Claimed benefit | About 50% cost saving on the Telstra project versus prior hydrogen technology (DiscoveryAlert summary of company material) |
Hy2 Hydrogen Energy Systems (now secondary)
| Model | Storage (company spec, hydrogen era) | Status |
|---|---|---|
| Hy2MINI | 425 kWh | Marketed 2022–2024; no disclosed commercial sale |
| Hy2MEDI (also called MIDI) | 2 MWh | Deployed in grant-funded Telstra TDRIP project |
| Hy2MEGA (also called MAXI) | 4 MWh or 250 kg hydrogen | Marketed; no disclosed sale |
| TOWER | Stackable storage towers to any size | Marketed; no disclosed sale |
Telstra Hy2MEDI configuration: solar array, electrolysers, hydrogen dryer, water purification, GKN metal hydride storage, dual fuel cells, alternative hydrogen generator, control system; claimed 7–10 days of storage in a small footprint (ASX announcement 3 Oct 2024). Later reconfigured to include low-pressure gaseous storage (FY2024 4E).
GKN HY2 Connect (digital platform)
Mobile/digital platform providing real-time data, alerts, AI control, simulation and predictive modelling for hydrogen systems (Yahoo Finance; roic.ai descriptions). No revenue or user metrics disclosed. Status after the hydrogen de-emphasis is not publicly disclosed.
Renewable sizing / modelling software
Developed under the Telstra project; described as adding significant IP and enabling accurate sizing of 100% renewable solutions at any location in Australia and Asia; slated for final testing in 2025 (FY2024 4E). Commercialisation status not publicly disclosed.
Turnkey Solar + Battery Solutions
Bundled solar and battery packages with finance options, launched October 2025 (TipRanks summary of 24 Oct 2025 update). Delivered via appointed installers in NSW, southern Queensland, WA and Victoria (HY2026).
Financial Narrative
All figures in A$ (whole dollars) from Appendix 4E reports unless stated. FY2021–FY2022 from FY2022 4E; FY2023 from FY2024 4E (restated comparative); FY2024 from FY2024 4E; FY2025 from FY2025 4E. "Derived" rows are analyst calculations from reported line items.
Margins and growth
Revenue CAGR FY2021–FY2025: approximately 33.2% per annum (A$422,984 to A$1,330,860). This headline is misleading: FY2021 revenue was residual contracting income, while FY2025 revenue is overwhelmingly government grant income under the Telstra TDRIP project, not product sales.
Commentary — income statement. The five-year arc has three phases. (1) FY2021–FY2022: wind-down of the Tempo contracting business, with large discontinued losses (A$3.80 million in FY2021) and a continuing-operations cost base still sized for a services company (employee costs A$2.08 million in FY2022). (2) FY2023–FY2024: a near-zero-revenue hydrogen development phase (revenue A$27,550 and A$43,108) during which management cut the cost base sharply; employee and director benefits fell 62% from FY2023 to FY2024, and total expenses fell 37%. (3) FY2025: grant-funded project execution lifted revenue to A$1.33 million, with offsetting pass-through costs (equipment and subcontractor costs of A$652,189 and project materials of A$79,864) and a rebuild of employee costs to A$858,757. Net loss narrowed every year from FY2021 to FY2025 (A$4.22 million to A$0.97 million), which is the single most consistent positive trend in the data, but the improvement reflects cost cutting and grant income rather than commercial traction.
Interest line anomaly: FY2025 interest and finance charges of A$34,253 sit alongside a cash flow statement that shows "interest and finance charges paid" as a positive A$34,642 and "interest received" as a negative A$33,139, which appears to be a sign/label transposition in the preliminary report (FY2025 4E, p.8). Flagged as a presentation inconsistency.
Balance sheet
Interim update at 30 June 2026 (HY2026 report): cash A$714,097; receivables A$794,853 (largely the R&D refund subsequently received on 13 July 2026); inventories A$59,918; intangibles A$2,230,907 (amortisation commenced in H1 2026 as development assets were brought into use, A$117,424 charge); total assets A$3,939,667; borrowings nil (insurance premium funding loan of A$41,915 repaid); total liabilities A$614,804; equity A$3,324,863; working capital A$1,162,018.
Commentary — balance sheet. The balance sheet is debt-free and small. A$88.2 million of accumulated losses against A$88.5 million of contributed equity at FY2025 is a stark record of historic capital destruction, most of it incurred during the Fermiscan and Tempo eras. Intangibles have grown from 9% of total assets (FY2021) to 69% (FY2025), meaning tangible equity is thin: at 30 June 2026 tangible equity was about A$1.09 million. The company recognised an impairment of A$120,600 in FY2024 and wrote off a non-current "other asset" of A$160,800 between FY2023 and FY2024; future impairment of hydrogen-related development assets is a monitorable given management's own downgrade of hydrogen to a secondary product. Contract liabilities (A$389,071 at FY2024; A$105,850 at FY2025) represent grant instalments received ahead of project delivery.
Cash flow
FY2021 receipts include discontinued contracting operations. FY2021 and FY2022 government grant receipts were not separately presented in the reviewed statements.
H1 2026 cash flow (HY2026 report): OCF -A$829,775; investing nil; equity proceeds A$941,491; share issue costs A$22,162; borrowings repaid A$41,914; net increase A$47,640. Quarterly operating outflows: approximately A$420,000 (Mar 2026 quarter) and A$411,000 (Jun 2026 quarter) (Appendix 4C summaries via InvestSMART).
Commentary — cash flow. H2G has not generated positive free cash flow in any of the five years. Cumulative FY2021–FY2025 free cash outflow was about A$9.09 million against cumulative equity raised of A$3.57 million; the gap was bridged by running down the A$6.64 million opening cash balance at the start of FY2021 (FY2022 4E comparatives) and by disposal proceeds. With opening cash now below A$1 million, the company is entirely dependent on annual R&D refunds (A$774,633 in July 2026), grant milestones and dilutive placements. At an operating burn of roughly A$1.6–1.7 million per year (two most recent quarters annualised), the July 2026 R&D receipt plus 30 June 2026 cash of A$714,097 implies runway of roughly 8–10 months from mid-2026 absent product revenue, broadly consistent with management's statement that the R&D receipt and February 2026 raise strengthen the cash position through 2026 and into 2027 (ASX announcement 13 Jul 2026).
Ratios
Net debt/EBITDA: not meaningful (net cash and negative EBITDA in every year). Cash conversion cycle: not publicly disclosed and not meaningful given negligible trade revenue. FY2021 ROE uses FY2020 closing equity of A$9,568,904 (FY2022 4E statement of changes in equity). FY2021 ROIC uses continuing EBIT and is distorted by management recharges.
Commentary — ratios. Every return metric is negative but improving in direction. Liquidity ratios look adequate in isolation (current ratio above 2x), but they reflect a shrinking balance sheet rather than strength; absolute working capital fell from A$3.79 million (FY2021) to A$0.56 million (FY2025) before the H1 2026 raise and R&D receivable lifted it to A$1.16 million. Leverage is immaterial.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment (AUD) and Segment Margins & Growth (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Renewable energy storage segment revenue from continuing operations (AUD) | 422,984 | 292,823 | 27,550 | 43,108 | 1,330,860 |
Segment pre-tax loss from continuing operations (AUD) | -421,606 | -2,512,936 | -1,750,291 | -1,156,623 | -974,347 |
Segment pre-tax margin (%) | -99.7 | -858.2 | -6,353.1 | -2,683.1 | -73.2 |
Revenue YoY growth (%) | 0 | -30.8 | -90.6 | 56.5 | 2,987.3 |
Share of total group revenue (%) | 100 | 100 | 100 | 100 | 100 |
Revenue by Segment (AUD)
| Metric | H1FY2025 | H1FY2026 |
|---|---|---|
Government customers revenue (AUD) | 527,556 | 579,590 |
Commercial customers revenue (AUD) | 0 | 12,507 |
R&D incentive classified as revenue (AUD) | 0 | 557,097 |
Government grant revenue (AUD) | 527,556 | 22,493 |
Revenue from contracts with customers (AUD) | 0 | 12,507 |
Interest income (AUD) | 15,468 | 18,435 |
Revenue by Segment (AUD) and Per-Share Data
| Metric | FY2021 | FY2022 |
|---|---|---|
Loss after tax from discontinued operations (AUD) | -3,797,302 | -743,811 |
Basic loss per share from discontinued operations (cents) | -1.05 | -0.20 |
Proceeds from disposal of business (AUD) | 0 | 653,741 |
Income Statement (AUD) and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue from continuing operations (AUD) | 422,984 | 292,823 | 27,550 | 43,108 | 1,330,860 |
Other income (AUD) | 9,415 | 19,186 | 186,968 | 47,263 | 34,945 |
Total revenue and other income (AUD) | 432,399 | 312,009 | 214,518 | 90,371 | 1,365,805 |
Direct project costs: materials plus equipment and subcontractor (AUD) | 173,899 | 253,312 | 7,688 | 30,863 | 732,053 |
Gross contribution, derived (AUD) | 249,085 | 39,511 | 19,862 | 12,245 | 598,807 |
Employee and director benefits expense (AUD) | 1,562,808 | 2,079,383 | 1,211,194 | 455,744 | 858,757 |
Total expenses from continuing operations (AUD) | 854,005 | 2,824,945 | 1,964,809 | 1,246,994 | 2,340,152 |
Depreciation and amortisation (AUD) | 123,221 | 81,112 | 10,024 | 4,227 | 3,765 |
Interest and finance charges (AUD) | 36,947 | 21,974 | 7,500 | 8,834 | 34,253 |
Operating income (EBIT), derived (AUD) | -384,659 | -2,490,962 | -1,742,791 | -1,147,789 | -940,094 |
EBITDA, derived (AUD) | -261,438 | -2,409,850 | -1,732,767 | -1,143,562 | -936,329 |
Pre-tax loss, continuing operations (AUD) | -421,606 | -2,512,936 | -1,750,291 | -1,156,623 | -974,347 |
Loss from discontinued operations (AUD) | -3,797,302 | -743,811 | 0 | 0 | 0 |
Net loss attributable to members (AUD) | -4,218,908 | -3,256,747 | -1,750,291 | -1,156,627 | -974,347 |
Basic EPS, total (A cents) | -1.16 | -0.88 | -0.42 | -0.24 | -0.15 |
Diluted EPS, total (A cents) | -1.16 | -0.88 | -0.42 | -0.24 | -0.15 |
Dividends per share (A cents) | 0 | 0 | 0 | 0 | 0 |
Weighted average shares, derived from EPS (millions) | 363.7 | 370.1 | 416.7 | 481.9 | 649.6 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross contribution margin, derived (%) | 58.9 | 13.5 | 72.1 | 28.4 | 45.0 |
Operating margin (%) | -90.9 | -850.7 | -6,325.9 | -2,662.6 | -70.6 |
EBITDA margin (%) | -61.8 | -823.0 | -6,289.5 | -2,652.8 | -70.4 |
Net margin, total net loss over revenue (%) | -997.4 | -1,112.2 | -6,353.1 | -2,683.1 | -73.2 |
Revenue YoY growth (%) | 0 | -30.8 | -90.6 | 56.5 | 2,987.3 |
Balance Sheet (AUD) and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (AUD) | 10,830,326 | 5,238,446 | 3,381,964 | 3,483,458 | 3,421,877 |
Cash and cash equivalents (AUD) | 3,970,985 | 2,250,855 | 1,002,386 | 1,041,385 | 666,457 |
Trade and other receivables (AUD) | 2,577,908 | 931,864 | 450,327 | 318,842 | 211,254 |
Inventories (AUD) | 166,221 | 0 | 0 | 0 | 96,204 |
Total current assets (AUD) | 8,108,221 | 3,324,021 | 1,573,094 | 1,446,779 | 1,057,145 |
Intangible assets, capitalised development, no goodwill (AUD) | 983,368 | 1,077,992 | 1,625,661 | 2,018,498 | 2,348,155 |
Short-term borrowings (AUD) | 853,841 | 49,920 | 49,191 | 43,029 | 41,915 |
Long-term borrowings (AUD) | 204,309 | 0 | 0 | 0 | 0 |
Total debt (AUD) | 1,058,150 | 49,920 | 49,191 | 43,029 | 41,915 |
Net debt, negative equals net cash (AUD) | -2,912,835 | -2,200,935 | -953,195 | -998,356 | -624,542 |
Total current liabilities (AUD) | 4,318,461 | 438,737 | 315,824 | 595,440 | 495,339 |
Total liabilities (AUD) | 4,719,773 | 483,729 | 377,538 | 653,438 | 576,797 |
Total equity (AUD) | 6,110,553 | 4,754,717 | 3,004,426 | 2,830,020 | 2,845,080 |
Contributed equity (AUD) | 84,948,858 | 86,548,193 | 86,548,193 | 87,530,414 | 88,519,821 |
Accumulated losses (AUD) | -81,058,452 | -84,296,215 | -86,046,506 | -87,203,133 | -88,177,480 |
Working capital (AUD) | 3,789,760 | 2,885,284 | 1,257,270 | 851,339 | 561,806 |
NTA per share (A cents, as reported) | 1.4 | 1.0 | 1.0 | 0.2 | 0.07 |
Cash Flow (AUD)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Receipts from customers (AUD) | 16,971,469 | 8,209,655 | 114,215 | 427,857 | 1,056,635 |
Government grants and tax incentives received (AUD) | 0 | 0 | 942,245 | 421,656 | 302,449 |
Operating cash flow (AUD) | -1,263,361 | -2,547,003 | -426,617 | -551,914 | -831,170 |
Capex, property plant and equipment (AUD) | 24,370 | 0 | 0 | 0 | 2,034 |
Capitalised development spend (AUD) | 983,368 | 863,311 | 821,123 | 241,592 | 530,017 |
Free cash flow, OCF less PP&E less capitalised development (AUD) | -2,271,099 | -3,410,314 | -1,247,740 | -793,506 | -1,363,221 |
Proceeds from share issues (AUD) | 0 | 1,599,335 | 0 | 982,221 | 989,407 |
Net borrowings flow (AUD) | -1,225,874 | -668,861 | -729 | -149,716 | -1,114 |
Dividends paid (AUD) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD) | 0 | 0 | 0 | 0 | 0 |
Net change in cash (AUD) | -2,665,676 | -1,720,130 | -1,248,469 | 38,999 | -374,928 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE, net loss over average equity (%) | -53.8 | -59.9 | -45.1 | -39.6 | -34.3 |
ROA, net loss over year-end total assets (%) | -39.0 | -62.2 | -51.8 | -33.2 | -28.5 |
ROIC, pre-tax EBIT over equity plus debt less cash (%) | -12.0 | -97.5 | -85.0 | -62.7 | -42.3 |
Current ratio (x) | 1.88 | 7.58 | 4.98 | 2.43 | 2.13 |
Debt to equity (x) | 0.173 | 0.010 | 0.016 | 0.015 | 0.015 |
Interest coverage, EBIT over interest (x) | -10.4 | -113.4 | -232.4 | -129.9 | -27.4 |
Asset turnover, revenue over year-end total assets (x) | 0.039 | 0.056 | 0.008 | 0.012 | 0.389 |
Revenue by Region (AUD) and Region Margins & Growth (%)
| Region | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Australia revenue from continuing operations (AUD) | 422,984 | 292,823 | 27,550 | 43,108 | 1,330,860 |
Rest of world revenue (AUD) | 0 | 0 | 0 | 0 | 0 |
Australia YoY growth (%) | 0 | -30.8 | -90.6 | 56.5 | 2,987.3 |
Segment Overview
| Segment | Australia share (%) | Other regions share (%) |
|---|---|---|
Renewable energy storage (single segment), FY2025 | 100 | 0 |
Valuation Snapshot
| Metric | Value | Date / source |
|---|---|---|
Recent share price | Approximately A$0.0105–A$0.012 | Aug–Sep 2026 (Stocklight; InvestSMART) |
Market capitalisation | Approximately A$9.6 million | Stocklight |
52-week range | A$0.006 to A$0.015 (Stocklight); A$0.006 to A$0.02 (alternate Stocklight page) | 2026 |
1-year change | Approximately flat to +20% (A$0.009–0.011 in Oct 2025 versus A$0.0105–0.012 recently) | Analyst estimate from observed prices |
3-year change | -80% (to May 2025) | Simply Wall St |
5-year change | -74.55% (to May 2025) | Simply Wall St |
Change since IPO | -99.53% (as TPP) | Simply Wall St |
Volatility | Average weekly movement about 100% (2025) | Simply Wall St |
Beta | 0.47 | Simply Wall St (2025) |
Share Count (millions) and Balance Sheet (AUD)
| Metric | FY2024 | FY2025 | H1FY2026 |
|---|---|---|---|
Shares on issue at period end (millions) | 598.18 | 694.73 | 799.34 |
Shares issued in period (millions) | 0 | 96.55 | 104.61 |
Equity raised gross (AUD) | 1,076,570 | 1,062,004 | 941,491 |
Returns & Leverage Ratios (AUD)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net equity proceeds in cash flow (AUD) | 0 | 1,599,335 | 0 | 982,221 | 989,407 |
Dividends per share (A cents) | 0 | 0 | 0 | 0 | 0 |
Buybacks (AUD) | 0 | 0 | 0 | 0 | 0 |
Valuation Multiples
| Multiple | H2G | Basis |
|---|---|---|
P/E | Not meaningful (loss-making) | — |
EV/EBITDA | Not meaningful (negative EBITDA) | — |
EV/Sales (TTM) | About 6.4x | EV approximately A$8.9 million (market cap less A$714,097 cash, nil debt) over TTM revenue A$1,395,401 (H2 2025 plus H1 2026, derived) |
Price/Sales (TTM) | About 6.9x | — |
Price/Book | About 2.9x | Equity A$3,324,863 at 30 Jun 2026 |
Price/Tangible book | About 8.8x | Tangible equity about A$1,093,956 |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None (0 analysts) |
Dividend policy | No dividends; none expected while loss-making |
Buyback authorisation | None (HY2026 Appendix 4D) |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Debt maturity profile | No interest-bearing debt at 30 Jun 2026; unused finance facilities of A$342,000 reported at Dec 2025 quarter (InvestSMART summary of 4C) |
Index membership | None (not in S&P/ASX All Ordinaries) |
ETF holdings | Not held by any ETF (InvestSMART) |
Analyst Conclusions
Management guidance
No revenue or earnings guidance. Management states revenue projections will be updated in future reports, and that product launches and partnerships will be significant contributors to future revenue (HY2026). Management also states the July 2026 R&D refund and February 2026 raise strengthen cash through 2026 and into 2027.
Consensus
No consensus estimates exist.
Bull case
-
Conversion of a pipeline worth roughly half the market cap. The disclosed sodium-ion pipeline of over A$4.5 million equals about 47% of the A$9.6 million market capitalisation. If even a third converts at reasonable gross margins in FY2027, revenue would exceed anything the current entity has generated from commercial customers, re-rating a stock trading at under 7x TTM sales that are mostly non-trading income.
-
Standards catalyst. If sodium-ion is incorporated into the Australian Standard and the CEC list, Model S becomes rebate-eligible. Because the company has pre-tested to SA TS 5398:2025 and already holds CEC-approved inverters, it could be among the first sodium-ion products listed, converting a structural handicap into a first-mover advantage.
-
Lean, debt-free cost base with non-dilutive top-ups. H1 2026 total expenses of A$1.04 million, nil debt and an annual R&D refund approaching A$0.8 million mean the company can sustain itself on small raises while optionality on data centre supercapacitor quotations (over A$10 million) remains open.
Bear case
-
Revenue quality is poor. FY2025's A$1.33 million and H1 2026's A$592,097 are overwhelmingly grants and R&D incentives; genuine commercial sales were A$12,507 in H1 2026. Pipeline figures have grown each quarter without a matching rise in customer receipts (A$20,000 in the March 2026 quarter).
-
Serial pivots and capital consumption. From contracting (Tempo) to hydrogen (GreenHy2) to sodium-ion and supercapacitors (H2G) in six years; accumulated losses of A$88.6 million; development spend on hydrogen now secondary. Each pivot has required fresh capital at lower prices, with share count up about 34% in 18 months.
-
Structural disadvantages in a commoditising market. No proprietary cells, undisclosed suppliers, no rebate access, and global competitors with scale and certified products. If lithium LFP prices keep falling, sodium-ion's cost pitch weakens before H2G achieves scale.
Catalysts and monitorables (next 12 months)
| Catalyst | Expected timing | What to watch |
|---|---|---|
| September 2026 quarterly / 4C | By end Oct 2026 | Customer receipts from first Model S shipments; cash balance after R&D refund |
| FY2026 Appendix 4E | Feb 2027 | Commercial revenue line; any impairment of hydrogen intangibles |
| Sodium-ion inclusion in Australian Standard / CEC list | Uncertain | Rebate eligibility |
| First Skeleton supercapacitor order | Uncertain | Conversion of the over A$10 million quotations |
| Telstra TDRIP performance outcome | 2026–2027 | Any follow-on Telstra contract |
| Distribution/wholesale agreements | Near term | Named partners and volume commitments |
| Next capital raise | Likely within 12 months | Price, size, participants |
| 2027 AGM and any board expansion | Apr–May 2027 | Independence and governance improvements |
Analyst verdict
H2G Limited is a nano-cap option on the commercialisation of sodium-ion home and C&I batteries in Australia, wrapped around a corporate shell with a long record of value destruction. The facts are unambiguous: accumulated losses of A$88.6 million, five consecutive years of negative free cash flow, and commercial product revenue that remains almost nil despite three years of product pivots. The headline FY2025 revenue growth (from A$43,108 to A$1.33 million) is a grant-accounting artefact, and the H1 2026 revenue line is 94% R&D tax incentive.
Against that, management has done several things right. The cost base has been cut and held: net losses narrowed in every year from FY2021 to FY2025 and fell another 33% in H1 2026. The balance sheet is debt-free. The company has exited a declining hydrogen thesis rather than sinking more capital into it, assembled a plausible sodium-ion product set with CEC-approved inverters and a claimed UL9540A-tested cell, and lifted its disclosed sodium-ion pipeline from about A$2 million to over A$4.5 million in roughly six months. A July 2026 R&D refund of A$774,633 buys time into 2027.
The investment question therefore reduces to two binary-like variables: whether Model S shipments convert into recurring sales through the newly appointed installer network over the next two to three quarters, and whether sodium-ion gains access to the Australian rebate framework. Until customer receipts in the quarterly 4C reports begin to track the pipeline, the stock should be regarded as speculative, illiquid and highly dilution-exposed, with governance (three directors, one independent, combined chair/MD) below institutional standards.
On balance, the evidence supports a stance of speculative watch, not investment-grade: the risk-reward improves materially only upon proof of commercial revenue (for example, quarterly customer receipts consistently above A$250,000) or confirmed rebate eligibility. Absent either, further dilutive raises at or below current prices are the base case.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Tenure | Prior roles | Education | Age |
|---|---|---|---|---|---|
Dr Paul Joseph Dalgleish | Executive Chairman and Managing Director | CEO from 15 Jul 2019; MD from 9 Feb 2023; Executive Chairman from 30 Sep 2023 | CEO, Executive Director and MD of RCR Tomlinson Ltd (2009–2018); CEO UGL Resources; MD Montgomery Watson Constructors | BEng (Hons), DBA, MA; FIEAust; MAICD | Born 1962 (approximately 64), per Yahoo Finance |
William Herbert Howard | Executive Director, CFO and Company Secretary | CFO/CoSec from 15 Jul 2019; Executive Director from 15 Aug 2019 | Not publicly disclosed in reviewed documents | — | — |
Michael Seder | Independent Non-Executive Director | From 25 Nov 2025 | Venture capitalist (M&A VC); over 15 years investing in 15+ ventures; 30+ years operational experience in retail and SaaS; independent NED of PINCHme.com, Inc. since 2020 (Motley Fool AU profile) | — | — |
“—” = not publicly disclosed.
Board of Directors — Charles Rottier
| Name | Role | Tenure | Notes |
|---|---|---|---|
Charles Rottier | Non-Executive Director | Mar 2020 to 2 Dec 2025 | Chair of Future Fuels CRC; former CEO Austin Engineering; former EGM Engineering & Construction, Transfield Services; retired citing completion of capital raise, new technology agreements and Seder's appointment |
Christopher James Cook | Non-Executive Director | 2021 to 9 Feb 2022 | CEO, Angophora Capital Pty Ltd (MarketScreener) |
Executive Leadership Team
| Name | Title |
|---|---|
Luc Bodart | Chief Engineer and General Manager |
Directors' Remuneration
| Executive | Total remuneration (AUD) | Year | Source |
|---|---|---|---|
Paul Dalgleish | 470,030 | Latest reported by aggregator, likely FY2024 | Yahoo Finance profile |
William Howard | 338,740 | Latest reported by aggregator, likely FY2024 | Yahoo Finance profile |
Governance Overview
| Attribute | Status |
|---|---|
Board size | 3 |
Independent directors | 1 of 3 (33%) |
Chair/CEO separation | No; Executive Chairman is also Managing Director |
Gender diversity | 0 of 3 directors female |
Committees | A "Risk, HSE and Commercial Committee" is referenced in the HY2026 risk note; audit, remuneration and nomination committee composition not disclosed in reviewed documents (with three directors, these functions are likely performed by the full Board) |
ASX Principles compliance | The company asserts compliance with the ASX Corporate Governance Principles (HY2026). However, a board without an independent majority and with a combined executive chair departs from Recommendations 2.4 and 2.5 and must be explained on an "if not, why not" basis in the Corporate Governance Statement. |
Major Shareholders
| Holder | Shares | Stake (%) | Basis |
|---|---|---|---|
Chembank Pty Limited | 24,999,999 | 4.18 | Motley Fool AU top holders (percentages on approximately 598 million shares, i.e. FY2024 register) |
Kimik Holdings Pty Limited | 15,151,516 | 2.53 | Same |
Bond Street Custodians Limited | 9,345,618 | 1.56 | Same |
Citicorp Nominees Pty Limited | 8,573,631 | 1.43 | Same |
Corey Michael McKerrow | 5,000,000 | 0.84 | Same |
Michael Seder / M&A VC fund | 27777778 (placement tranche) | 3.5 (approx. on 799.3 million shares) | — |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Positioning vs H2G |
|---|---|---|
Residential home batteries (Australia) | Tesla (Powerwall) | Category leader; brand, scale, rebate-eligible |
Residential home batteries | BYD (Battery-Box) | Major LFP supplier, vertically integrated cells |
Residential home batteries | Sungrow | Inverter-plus-battery bundles, strong installer channel |
Residential home batteries | Sigenergy | Fast-growing integrated storage systems |
Residential home batteries | AlphaESS | Established Australian channel presence |
Residential home batteries | Enphase | Microinverter-integrated storage |
Residential home batteries | LG Energy Solution | Tier-1 cell maker with residential products |
Sodium-ion cells / systems (global) | CATL | Global leader announcing sodium-ion cells; likely upstream cost-setter |
Sodium-ion cells / systems (global) | HiNa Battery and other Chinese sodium-ion producers | Potential suppliers and competitors |
Non-flammable / alternative chemistries (Australia) | Altech Batteries (ASX: ATC, CERENERGY sodium-chloride solid-state) | ASX-listed alternative-chemistry peer, pre-commercial |
Non-flammable / alternative chemistries (Australia) | Redflow (zinc-bromine flow) | Former ASX peer; entered administration in 2024, illustrating sector risk |
Data centre critical power / UPS | Vertiv, Schneider Electric, Eaton | Incumbent UPS/storage suppliers with deep data centre relationships |
Hydrogen storage for SAPS | GKN Hydrogen, H2Core (direct sales), other integrators | Hydrogen market largely ceded by H2G |
Peer Comparison FY2025
| Metric | H2G Limited (FY2025) | Tesla Energy Generation & Storage segment (CY2024) | CATL (CY2024) |
|---|---|---|---|
Revenue | A$1.33 million (mostly grants) | Approximately US$10 billion | Approximately RMB 362 billion |
Revenue growth | +2,987% (low base) | Approximately +67% | Approximately -10% |
Operating margin | -70.6% | Positive (segment gross margin reported above 20%) | Positive |
R&D intensity | Capitalised dev 39.8% of revenue | Not separately reported for segment | Approximately 5% of revenue |



